Mark Robert Baker serves as Executive at PROGENICS PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Mark Robert Baker has executed 110 insider transactions totaling $304.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 3, 2007 involved exercising options for 571 shares valued at $12.5K.
Mark Robert Baker currently holds 161,041 shares of PROGENICS PHARMACEUTICALS INC (PGNX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark Robert Baker has been a net buyer of PGNX stock. They have purchased $275.9K and sold $28.2K worth of shares.
Mark Robert Baker's most recent insider trade was on Jan 3, 2007, when they sold 571 shares at $21.88 per share.
Get notified when new Form 4 filings are submitted
| 627 |
| $19.58 |
| Discretionary |
| Oct 2, 2006 | PGNX | $13.2K | Payment | 571 | $23.03 | Discretionary |
| Jul 3, 2006 | PGNX | $0 | Award | 8,000 | $N/A | Discretionary |
| Jul 3, 2006 | PGNX | $67.2K | Payment | 2,768 | $24.26 | Discretionary |
| Jul 3, 2006 | PGNX | $76.4K | Option Exercise | 3,056 | $25.01 | Discretionary |
| Apr 3, 2006 | PGNX | $11.6K | Payment | 454 | $25.61 | Discretionary |
| Apr 3, 2006 | PGNX | $10.9K | Option Exercise | 500 | $21.77 | Discretionary |
| Jan 3, 2006 | PGNX | $11.2K | Option Exercise | 539 | $20.86 | Discretionary |
| Jan 3, 2006 | PGNX | $12.3K | Payment | 477 | $25.84 | Discretionary |